JPMorgan Chase: Increases CrowdStrike Target Price from $372 to $418
白云追月素
发表于 어제 11:41
120
0
0
According to Securities Times Online, JPMorgan Chase has raised its target stock price for CrowdStrike from $372 to $418 and maintained an "increase in holdings" rating. CrowdStrike primarily provides cloud based endpoint protection platforms, with revenue mainly coming from subscription sales (93.9%) and professional service sales (6.1%), with the highest market share in the United States (68.4%).
FactSet survey shows that analysts have an average rating of "overweight" for CrowdStrike, with an average target price of $380.15. This reflects the market's optimistic expectations for CrowdStrike's future performance. In addition to JPMorgan Chase, several other investment banks have also made rating adjustments to CrowdStrike. Mizuho Securities has raised its target stock price from $375 to $385, maintaining its "outperform the market" rating. Daiwa Securities raised its target share price from $315 to $388.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
You may like
- Morgan Stanley raises Reddit target price to $200
- JPMorgan Chase: Increases Netflix Target Price to $1010
- Investment bank Needham raises Reddit's target price from $120 to $190 to maintain a 'buy' rating
- Goldman Sachs: Increases Costco target price to $1052
- RBC Capital raises target prices for multiple US bank stocks
- Morgan Stanley raises IBM target price to $222
- JPMorgan Chase: Upgrades CBRE rating to $163 increase target price
- Morgan Stanley raises Netflix target price from $830 to $1050
-
12월 18일, 중국국가약품감독관리국은 EliLillyandCompany (이하"예래"로 략칭함.) 의 알츠하이머병요법을 비준하고 기능달 & amp;reg;(도네 단항 주사액, 4주마다 정맥 주입) 성인이 알츠하이머병으로 인한 경도 ...
- 我是来围观的逊
- 어제 20:25
- Up
- Down
- Reply
- Favorite
-
"브로드컴의 시가총액이 조 달러를 돌파한 맞춤형 AI 칩이 엔비디아를'호칭'할 수 있을까?" 엔비디아, 인텔이 주로 컴퓨팅 칩을 생산하는 것과 달리 브로드컴은 주로 네트워크 연결에 사용되는 칩 제품을 생산한다. ...
- 我是来围观的逊
- 그저께 17:58
- Up
- Down
- Reply
- Favorite
-
신경보소식: 12월 18일, 례래 공식위챗공중번호는 그 알츠하이머병요법 도네단항주사액 (상품명기 능달 & amp; reg;,4주마다 정맥주입) 국가약품감독국의 비준을 받아 성인이 알츠하이머병으로 인한 경도인지기능장 ...
- oralpapapa
- 어제 17:07
- Up
- Down
- Reply
- Favorite
-
[소식에 따르면 머스크는 TSMC 회장 위철가와 만나 로봇이 테슬라의 미래의 중심이라고 밝혔다.] 보도에 따르면 테슬라 CEO 엘론 머스크는 지난주 미국에서 TSMC 회장 위철가를 만났다.위철가는 "전 세계에서 가장 ...
- 明绍宗朱聿键鼻
- 그저께 15:19
- Up
- Down
- Reply
- Favorite